Educational Objectives:

At the end of this activity, all participants should be able to:

  • Discuss strategies to improve the knowledge, skills or performance of the healthcare team.

Opening Session- Preventive Strategies for Optimal Cardiometabolic Health

  1. Discuss key quality metrics in clinical practice settings 
  2. Discuss strategies for implementing preventive care in healthcare systems
  3. Describe how the CKM prevent calculator is used in clinical practice
  4. Describe how social determinants can impact healthcare delivery and disparities

 

Session II- The vital role of lipids in the heart brain axis  

  1. Describe role of APOE in lipid metabolism
  2. Assess the physiological and biochemical pathways linking heart health and brain function
  3. Discuss evidence-based strategies for dementia prevention 

 

Session III- Beyond the Basics: Optimizing Women’s Wellness

  1. Explore holistic strategies that address multifaceted aspects of women’s cardiometabolic health
  2. Identify the changes in lipid profiles associated with menopause and perimenopause
  3. Discuss the role of Lp(a) in influencing cardiometabolic risk factors in women 

 

Session IV- Publications of the NLA 

  1. Describe current evidence-based recommendations of importance to the practice of clinical lipidology

 

Session V- Lipid Scholar Case Discussion 

  1.  Discuss strategies for the management of patients with lipid disorders using a case-based approach
     

Session VI- Targeting apoB lipoproteins in the clinic; fireside chat with expert clinicians

  1. Recognize the role of apolipoprotein B (ApoB) as a universal target for ASCVD prevention
  2. Discuss common clinical challenges related to targeting apoB lipoproteins
  3. Discuss strategies for the management of patients with lipid disorders  

 

Session VII- Addressing obesity and weight loss challenges: Implications for cardiometabolic health

  1. Analyze the impact of weight loss on cardiometabolic health and discuss its implications for managing obesity-related challenges
  2. Discuss the role of bariatric surgery in improving cardiometabolic health
  3. Assess the clinical application of incretin mimetics including side effects in managing weight loss challenges

 

Session VIII- Questions from the clinic: Addressing severe HTG

  1. Identify the underlying causes of severe hypertriglyceridemia and assess patient risk factors
  2. Discuss dietary strategies to manage severe hypertriglyceridemia 
  3. Appraise therapeutic strategies to manage patients with severe hypertriglyceridemia

 

Session IX- Enhancing pediatric health: Strategies for early intervention  

  1. Evaluate application of lipid screening in pediatric cohorts
  2. Analyze effective strategies to prevent and manage childhood obesity
  3. Identify the unique health needs of diverse pediatric populations and discuss tailored early intervention strategies to improve health outcomes 

 

CME/CE credit provided by the National Lipid Association 

In support of improving patient care, this activity has been planned and implemented by The National Lipid Association. The National Lipid Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit Designation Statement 
The National Lipid Association designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in this activity. 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.0 AMA PRA Category 1 Credits™ MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Dietitians
The National Lipid Association is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 12.0 continuing professional education units (CPEUs) for completion of this program/ materials. CDR Accredited Provider #NL002.

Pharmacists

Universal Activity Number - JA0007192-0000-24-031-L01-P (Application)
This Activity has been approved for 12.0 contact hour(s) (1.20 CEUs) of the Accreditation Council for Pharmacy Education

Nursing
The maximum number of hours awarded for this CE activity is 12.0 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined.

 

 

CRITERIA FOR SUCCESS:
Statements of credit will be awarded based on the participant´s attendance and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.lipid.org/cme. The deadline to claim credit is November 17, 2025. Questions related to this content should be sent to cme@lipid.org.

 

FOR PHARMACISTS: Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

FOR DIETITIANS: Upon completion of the activity evaluation form, dietitians may submit evaluations of the quality of activities/materials to CDR. Poor evaluations of activities/materials may trigger an audit of the activities / materials by CDR.

COMMERCIAL SUPPORT
Full notification of commercial support will be provided in the meeting application.

DISCLOSURE OF UNLABELED USE AND INVESTIGATIONAL PRODUCTS
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLOSURE DECLARATION
It is the policy of NLA to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. Planners, faculty, reviewers, and staff have disclosed any financial relationships with commercial interests as defined by the ACCME. 

DISCLAIMER
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. The NLA specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through reader’s misunderstanding of content.

PERMISSIONS
The National Lipid Association acknowledges that permissions have been obtained for use of all copyrighted materials, including graphs, tables, pictures, and charts printed in this activity syllabus. Permissions have also been obtained from identifiable patients in photographs and other images, consistent with the DHHS HIPAA regulations for individual privacy.